121 related articles for article (PubMed ID: 36049476)
21. Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study.
Shin YU; Cho H; Kim JM; Bae K; Kang MH; Shin JP; Nam E; Kang SW;
Medicine (Baltimore); 2016 Nov; 95(44):e5185. PubMed ID: 27858854
[TBL] [Abstract][Full Text] [Related]
22. Role of the Apolipoprotein E Polymorphisms in the Development of Retinal Vein Occlusion in a Tunisian Population: A Case-Control Study.
Mrad M; Fekih-Mrissa N; Wathek C; Sayeh A; Maalej A; Rannen R; Nsiri B
Clin Appl Thromb Hemost; 2017 Sep; 23(6):645-651. PubMed ID: 26851238
[TBL] [Abstract][Full Text] [Related]
23. Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study.
Christiansen CB; Torp-Pedersen C; Olesen JB; Gislason G; Lamberts M; Carlson N; Buron M; Juul N; Lip GYH
BMC Cardiovasc Disord; 2018 May; 18(1):91. PubMed ID: 29743025
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.
Ponto KA; Elbaz H; Peto T; Laubert-Reh D; Binder H; Wild PS; Lackner K; Pfeiffer N; Mirshahi A
J Thromb Haemost; 2015 Jul; 13(7):1254-63. PubMed ID: 25894549
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.
Becatti M; Marcucci R; Gori AM; Mannini L; Grifoni E; Alessandrello Liotta A; Sodi A; Tartaro R; Taddei N; Rizzo S; Prisco D; Abbate R; Fiorillo C
J Thromb Haemost; 2016 Nov; 14(11):2287-2297. PubMed ID: 27557753
[TBL] [Abstract][Full Text] [Related]
26. Pachychoroid disease and its association with retinal vein occlusion: a case-control study.
Keidel LF; Zwingelberg S; Schworm B; Luft N; Herold T; Priglinger SG; Siedlecki J
Sci Rep; 2021 Oct; 11(1):19854. PubMed ID: 34615888
[TBL] [Abstract][Full Text] [Related]
27. Association study of high-frequency variants of
Fernández-Vega B; Álvarez L; García M; Artime E; González Fernández A; Fernández-Vega C; Nicieza J; Vega JA; González-Iglesias H
Ophthalmic Genet; 2019 Aug; 40(4):342-349. PubMed ID: 31418317
[No Abstract] [Full Text] [Related]
28. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.
Khayat M; Williams M; Lois N
Surv Ophthalmol; 2018; 63(6):816-850. PubMed ID: 29705175
[TBL] [Abstract][Full Text] [Related]
29. Impact of statin treatment on cardiovascular events in patients with retinal vein occlusion: a nested case-control study in Korea.
Yoo J; Shin JY; Jeon J; Kim J
Epidemiol Health; 2023; 45():e2023035. PubMed ID: 36996869
[TBL] [Abstract][Full Text] [Related]
30. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.
Mrad M; Wathek C; Saleh MB; Baatour M; Rannen R; Lamine K; Gabsi S; Gritli N; Fekih-Mrissa N
Transfus Apher Sci; 2014 Apr; 50(2):283-7. PubMed ID: 24440586
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.
Ortak H; Söğüt E; Ateş O; Erkorkmaz U; Benli I; Akbas A; Demir S; Ozyurt H
Mol Vis; 2013; 19():486-xxx. PubMed ID: 23441121
[TBL] [Abstract][Full Text] [Related]
32. Association of Retinal Vascular Occlusion With Women Filling a Prescription for Female Hormone Therapy.
Song D; Nadelmann J; Yu Y; VanderBeek BL
JAMA Ophthalmol; 2021 Jan; 139(1):42-48. PubMed ID: 33180101
[TBL] [Abstract][Full Text] [Related]
33. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.
Xu K; Wu L; Ma Z; Liu Y; Qian F
Acta Ophthalmol; 2019 May; 97(3):e364-e372. PubMed ID: 30239140
[TBL] [Abstract][Full Text] [Related]
34. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study.
Ponto KA; Scharrer I; Binder H; Korb C; Rosner AK; Ehlers TO; Rieser N; Grübel NC; Rossmann H; Wild PS; Feltgen N; Pfeiffer N; Mirshahi A
J Hypertens; 2019 Jul; 37(7):1372-1383. PubMed ID: 31145709
[TBL] [Abstract][Full Text] [Related]
35. Retinal venous occlusion and ABO blood-groups.
White LE
N Z Med J; 1978 Feb; 87(606):124-6. PubMed ID: 274647
[TBL] [Abstract][Full Text] [Related]
36. Risk of retinal vein occlusion in patients with diabetes mellitus: A retrospective cohort study.
Chang YS; Ho CH; Chu CC; Wang JJ; Jan RL
Diabetes Res Clin Pract; 2021 Jan; 171():108607. PubMed ID: 33310122
[TBL] [Abstract][Full Text] [Related]
37. ENDOTHELIN-1 AS A RISK FACTOR IN RETINAL VEIN OCCLUSION.
List W; Weger M; Pinter-Hausberger S; Posch F; Rabensteiner J; Pailer S; Wedrich A; Posch-Pertl L
Retina; 2022 Apr; 42(4):738-743. PubMed ID: 34861658
[TBL] [Abstract][Full Text] [Related]
38. [Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].
Rosner AK; Closs EI; Habermeier A; Gericke A; Binder H; Scharrer I; Pfeiffer N; Ponto KA
Ophthalmologe; 2021 Jul; 118(7):684-690. PubMed ID: 32940851
[TBL] [Abstract][Full Text] [Related]
39. Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors - a population-based cohort study.
Lee WA; Chung WP; Shao SC; Lai EC; Chen YC; Ho CH
BMC Cancer; 2023 Jun; 23(1):545. PubMed ID: 37316803
[TBL] [Abstract][Full Text] [Related]
40. Elevated Neutrophil Counts, Triglycerides, Monocyte/High-Density Lipoprotein Ratios, and Lower High-Density Lipoprotein in Patients with Retinal Vein Occlusion.
Pan M; Zhou P; Guo J; An G; Liu Z; Du L; Jin X
Ophthalmic Res; 2023; 66(1):265-271. PubMed ID: 36223733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
